Masaryk University CEITEC
Brno, 62500, Czechia
Location status: Recruiting
NCT Number: NCT05847985
Lewy body diseases (LBDs) represents a group of neurodegenerative disorders characterized by the abnormal accumulation of aggregates of α-synuclein protein leading to the formation of Lewy bodies (LB) and Lewy neurites resulting in cell death. LBDs consists of two major clinical entities - Parkinson's disease (PD) and dementia with LB (DLB). Vast majority of patients with LBDs either already have mild cognitive impairment (MCI) at the time of the diagnosis or will develop it during the course of the disease. Language dysfunctions in LBDs patients with MCI are often unrecognized, which are difficult to treat, but even subtle changes might lead to impairment of social and occupational functioning with profound effect on their quality of lives. Current pharmacological or surgical strategies are effective for tackling the motor issues of LBDs with very limited effects on other symptoms such as language dysfunctions. Therefore, non-pharmacological approaches are gaining more attention. One of these non-pharmacological strategies is the use of noninvasive brain stimulation (NIBS) techniques that are able to modulate the brain functions with the effects on human nervous system plasticity. In this proposed project the investigators aim to first describe specific alterations in the language domain in LBDs patients with MCI as compared to healthy controls (HC) and identify the neural underpinnings of these changes using novel combination of advanced multimodal imaging techniques and various analytical methods. Secondly, the investigators aim to use NIBS as a supervised and individualized home-based therapeutical approach to tackle the language dysfunctions.
Interested in participating?
Request Info60 year–80 year
All sexes
Interventional
Not applicable
Brno, 62500, Czechia
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
tDCS using electric currents to modulate underlying neurons
Time frame: through study completion, an average of 1 year
the investigators will study comprehension of syntactically complex sentences - accuracy in sentence comprehension task
Time frame: through study completion, an average of 1 year
the investigators will study comprehension of syntactically complex sentences - reaction times in sentence comprehension task
Time frame: through study completion, an average of 1 year
the investigators will correlate sentence comprehension with cognitive functions: z-scores in following domains - memory, attention, executive function, visuospatial function and language function of Short Neuropsychological Battery (Bolcekova et al. 2020)
Time frame: through study completion, an average of 1 year
The investigators will identify connectivity differences between HC and LBDs patients with MCI in language-related domain-specific and domain-general networks. In the task-based fMRI study, LBDs patients with MCI will show reduced activation and altered functional connectivity within and between these large-scale cortical networks compared to HC.
Time frame: through study completion, an average of 1 year
Abnormal intra- and inter-network dynamics will be apparent in resting-state fMRI of LBDs patients with MCI as compared to HC.
Time frame: through study completion, an average of 1 year
LBDs patients with MCI will show structural changes in language-related domain-specific and domain-general networks with neural degeneration as assessed by NMS-MRI as compared to HC.
Time frame: On the beginning of the study, after completion of two-week stimulation a eight weeks after the baseline assessment
the investigators will investigate the long-term effects of repeated sessions of home-based tDCS on sentence comprehension of syntactically complex sentences - accuracy in sentence comprehension task (as was described in outcome 1)
Time frame: On the beginning of the study, after completion of two-week stimulation a eight weeks after the baseline assessment
the investigators will investigate the long-term effects of repeated sessions of home-based tDCS on sentence comprehension of syntactically complex sentences - reaction times in sentence comprehension task (as was described in outcome 2)
Time frame: On the beginning of the study, after completion of two-week stimulation a eight weeks after the baseline assessment
the investigators will investigate the long-term effects of repeated sessions of home-based tDCS on resting state data (as was described in outcome 5)
Time frame: On the beginning of the study, after completion of two-week stimulation a eight weeks after the baseline assessment
the investigators will investigate the long-term effects of repeated sessions of home-based tDCS on sentence comprehension fMRI task data (as was described in outcome 4)
Time frame: On the beginning of the study, after completion of two-week stimulation a eight weeks after the baseline assessment
the investigators will investigate the long-term effects of repeated sessions of home-based tDCS on structural MRI data (as was described in outcome 6)
Contact information is provided by the study sponsor or research team.
Masaryk University
Other
Acronym: LANG-LBD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07589595
Alzheimer Disease, Amyloid
Chandler, Arizona, United States
View Trial DetailsNCT02795052
ALS, Alzheimer Disease
Westport, Connecticut, United States
View Trial DetailsNCT07545473
Alzheimer Disease, Arterial Occlusive Diseases
Melbourne, Victoria, Australia
View Trial DetailsNCT07533799
Basal Ganglia Diseases, Brain Diseases
Malmö, Sweden
View Trial Details